Channel Medsystems is a medical device company founded in 2009 and headquartered in the United States. The company's slogan is "Empowering every woman to take control of her health journey and live her best life." Channel Medsystems is dedicated to delivering innovative technologies that exceed the expectations of women and their gynecologists with a focus on developing easy-to-use, safe, and cost-effective medical devices. Led by chief executive officer Ric Cote, Channel Medsystems has a seasoned executive leadership team with a track record of commercializing innovative medical devices. The company's technology, Cerene® Cryotherapy, is a well-tolerated in-office endometrial ablation treatment that safely and effectively reduces heavy menstrual bleeding without general anesthesia. This treatment preserves access to the uterine cavity for future diagnostic evaluations. The company's commitment to exceptional outcomes and patient comfort is reflected in their dedication to making these technologies accessible to all women. Channel Medsystems recently secured a $5.00M Venture Round investment on 15 March 2024. The details about the investors involved in this recent investment round are not disclosed. For additional information on the safety of the company's technology, interested parties can review the provided safety info link (https://bit.ly/3qgfAtS).
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $5.00M | - | 15 Mar 2024 | |
Venture Round | $10.01M | - | 03 May 2023 | |
Series C | $14.10M | 6 | 23 Aug 2017 | |
Series C | $22.00M | 6 | 22 Sep 2015 | |
Debt Financing | $6.00M | - | 15 Oct 2014 |
No recent news or press coverage available for Channel Medsystems.